Skip to main content
Erschienen in: Journal of Neurology 11/2014

01.11.2014 | Original Communication

The presence of dysautonomia in different subgroups of myasthenia gravis patients

verfasst von: Ana Nikolić, Stojan Perić, Tanja Nišić, Srdjan Popović, Miroljub Ilić, Vidosava Rakočević Stojanović, Dragana Lavrnić

Erschienen in: Journal of Neurology | Ausgabe 11/2014

Einloggen, um Zugang zu erhalten

Abstract

To analyze the presence of autonomic dysfunction in different subgroups of myasthenia gravis (MG) patients. Standard cardiovascular reflex tests according to Ewing, spectral and time domain analysis of heart rate variability (HRV) at rest were assessed in 27 patients with thymoma-associated acetylcholine receptor (AChR)-positive MG, 25 AChR-positive MG patients without thymoma and 23 patients with muscle-specific tyrosine kinase (MuSK) MG. All patients were compared to the healthy controls, matched for sex and age. In the group of AChR-positive MG patients with thymoma, hand grip (p < 0.05), orthostasis (p < 0.05), breathing test (p < 0.05) and Valsalva maneuver (p < 0.01) were more often pathological than in the controls. Analysis of the spectral domain of HRV showed increased low-frequency (p < 0.05) and decreased high-frequency component (p < 0.05). Time domain parameters of HRV and baroreflex sensitivity (BRS) at rest were significantly reduced (p < 0.01). In the patients with AChR MG without thymoma, Valsalva maneuver test was more often pathological (p < 0.05) and higher rate of supraventricular extrasystoles (p < 0.01) was registered than in the healthy controls. In the patients with MuSK-positive MG, hand grip and Valsalva maneuver tests were more often pathological than in the controls (p < 0.05). Low-frequency component of the spectral domain of HRV (p < 0.05) and the frequency of cardiac arrhythmia were increased. BRS at rest was significantly lower in patients compared to the controls (p < 0.01). We determined the presence of autonomic failure in all subgroups of MG patients. Since autonomic dysfunction can lead to cardiac arrhythmias and even sudden death, it is of major importance to be aware of this association and to properly diagnose and treat these patients.
Literatur
1.
2.
Zurück zum Zitat Evoli A, Padua L, Monaco ML, Scuderi F, Batocchi AP, Marino M, Bartoccioni E (2003) Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis. Brain 126:2304–2311CrossRefPubMed Evoli A, Padua L, Monaco ML, Scuderi F, Batocchi AP, Marino M, Bartoccioni E (2003) Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis. Brain 126:2304–2311CrossRefPubMed
3.
Zurück zum Zitat Stoica E, Enulescu O (1992) Deficiency of sympathetic nervous system function in myasthenia. J Auton Nerv Syst 38:69–76CrossRefPubMed Stoica E, Enulescu O (1992) Deficiency of sympathetic nervous system function in myasthenia. J Auton Nerv Syst 38:69–76CrossRefPubMed
4.
Zurück zum Zitat Lechin F, van der Dijs B, Pardey-Maldonado B et al (2000) Enhancement of noradrenergic neural transmission: an effective therapy of myasthenia gravis: a report on 52 consecutive patients. J Med 31:333–361PubMed Lechin F, van der Dijs B, Pardey-Maldonado B et al (2000) Enhancement of noradrenergic neural transmission: an effective therapy of myasthenia gravis: a report on 52 consecutive patients. J Med 31:333–361PubMed
5.
Zurück zum Zitat Peric S, Rakocevic Stojanovic V, Nisic T et al (2011) Cardiac autonomic control in patients with myasthenia gravis and thymoma. J Neurol Sci 307:30–33CrossRefPubMed Peric S, Rakocevic Stojanovic V, Nisic T et al (2011) Cardiac autonomic control in patients with myasthenia gravis and thymoma. J Neurol Sci 307:30–33CrossRefPubMed
6.
Zurück zum Zitat Vernino S, Lennon VA (2004) Autoantibody profiles and neurological correlations of thymoma. Clin Cancer Res 10:7270–7275CrossRefPubMed Vernino S, Lennon VA (2004) Autoantibody profiles and neurological correlations of thymoma. Clin Cancer Res 10:7270–7275CrossRefPubMed
7.
Zurück zum Zitat Vernino S, Hopkins S, Wang Z (2009) Autonomic ganglia, acetylcholine receptor antibodies, and autoimmune ganglionopathy. Auton Neurosci 146:3–7PubMedCentralCrossRefPubMed Vernino S, Hopkins S, Wang Z (2009) Autonomic ganglia, acetylcholine receptor antibodies, and autoimmune ganglionopathy. Auton Neurosci 146:3–7PubMedCentralCrossRefPubMed
8.
Zurück zum Zitat Lavrnic D, Losen M, Vujic A et al (2005) The features of myasthenia gravis with autoantibodies to MuSK. J Neurol Neurosurg Psychiatry 76:1099–1102PubMedCentralCrossRefPubMed Lavrnic D, Losen M, Vujic A et al (2005) The features of myasthenia gravis with autoantibodies to MuSK. J Neurol Neurosurg Psychiatry 76:1099–1102PubMedCentralCrossRefPubMed
9.
Zurück zum Zitat Lauriola L, Ranelletti F, Maggiano N et al (2005) Thymus changes in anti-MuSK-positive and -negative myasthenia gravis. Neurology 64:536–538CrossRefPubMed Lauriola L, Ranelletti F, Maggiano N et al (2005) Thymus changes in anti-MuSK-positive and -negative myasthenia gravis. Neurology 64:536–538CrossRefPubMed
10.
Zurück zum Zitat Leite MI, Strobel P, Jones M et al (2005) Fewer thymic changes in MuSK antibody-positive than in MuSK antibody-negative MG. Ann Neurol 57:444–448CrossRefPubMed Leite MI, Strobel P, Jones M et al (2005) Fewer thymic changes in MuSK antibody-positive than in MuSK antibody-negative MG. Ann Neurol 57:444–448CrossRefPubMed
11.
Zurück zum Zitat Jeretzki A 3rd, Barohn RJ, Ernstoff RM et al (2000) Myasthenia gravis: recommendations for clinical research standards. Task force of the Medical Scientific Advisory Board of the Myasthenia gravis Foundation of America (review). Neurology 55:16–23CrossRef Jeretzki A 3rd, Barohn RJ, Ernstoff RM et al (2000) Myasthenia gravis: recommendations for clinical research standards. Task force of the Medical Scientific Advisory Board of the Myasthenia gravis Foundation of America (review). Neurology 55:16–23CrossRef
12.
Zurück zum Zitat Ewing D (1992) Analysis of heart rate variability and other non-invasive tests with special reference to diabetes mellitus. In: Mathias C, Bannister R (eds) Autonomic failure: a textbook of clinical disorders of the autonomic nervous system, 3rd edn. Oxford University Press, London, pp 312–333 Ewing D (1992) Analysis of heart rate variability and other non-invasive tests with special reference to diabetes mellitus. In: Mathias C, Bannister R (eds) Autonomic failure: a textbook of clinical disorders of the autonomic nervous system, 3rd edn. Oxford University Press, London, pp 312–333
13.
Zurück zum Zitat Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology (1996) Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Eur Heart J 17:354–381CrossRef Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology (1996) Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Eur Heart J 17:354–381CrossRef
15.
Zurück zum Zitat Shukla G, Gupta S, Goyal V, Singh S, Srivastava A, Behari M (2013) Abnormal sympathetic hyper-reactivity in patients with myasthenia gravis: a prospective study. Clin Neurol Neurosurg 115:179–186CrossRefPubMed Shukla G, Gupta S, Goyal V, Singh S, Srivastava A, Behari M (2013) Abnormal sympathetic hyper-reactivity in patients with myasthenia gravis: a prospective study. Clin Neurol Neurosurg 115:179–186CrossRefPubMed
16.
Zurück zum Zitat Sivan Puneeth C, Retanaswami Chandra S, Yadav R, Narasappa Sathyaprabha T, Chandran S (2013) Heart rate and blood pressure variability in patients with myasthenia gravis. Ann Indian Acad Neurol 16:329–332CrossRef Sivan Puneeth C, Retanaswami Chandra S, Yadav R, Narasappa Sathyaprabha T, Chandran S (2013) Heart rate and blood pressure variability in patients with myasthenia gravis. Ann Indian Acad Neurol 16:329–332CrossRef
17.
Zurück zum Zitat Gunal DI, Afsar N, Tanridag T, Aktan S (2002) Autonomic dysfunction in multiple sclerosis: correlation with disease-related parameters. Eur Neurol 48:1–5CrossRefPubMed Gunal DI, Afsar N, Tanridag T, Aktan S (2002) Autonomic dysfunction in multiple sclerosis: correlation with disease-related parameters. Eur Neurol 48:1–5CrossRefPubMed
18.
Zurück zum Zitat Lennon V, Ermilov LG, Szurszewski JH, Vernino S (2003) Immunization with neuronal nicotinic acetylcholine receptor induces neurological autoimmune disease. J Clin Invest 111:907–913PubMedCentralCrossRefPubMed Lennon V, Ermilov LG, Szurszewski JH, Vernino S (2003) Immunization with neuronal nicotinic acetylcholine receptor induces neurological autoimmune disease. J Clin Invest 111:907–913PubMedCentralCrossRefPubMed
19.
Zurück zum Zitat Miglis MG, Racela R, Kaufmann H (2011) Seropositive myasthenia and autoimmune autonomic ganglionopathy: cross reactivity or subclinical disease? Auton Neurosci 164:87–88CrossRefPubMed Miglis MG, Racela R, Kaufmann H (2011) Seropositive myasthenia and autoimmune autonomic ganglionopathy: cross reactivity or subclinical disease? Auton Neurosci 164:87–88CrossRefPubMed
20.
21.
Zurück zum Zitat Amenta AR, Creely HE, Mercado ML et al (2012) Biglycan is an extracellular MuSK binding protein important for synapse stability. J Neurosci 32:2324–2334PubMedCentralCrossRefPubMed Amenta AR, Creely HE, Mercado ML et al (2012) Biglycan is an extracellular MuSK binding protein important for synapse stability. J Neurosci 32:2324–2334PubMedCentralCrossRefPubMed
22.
Zurück zum Zitat Ksiazek I, Burkhardt C, Lin S et al (2007) Synapse loss in cortex of agrin-deficient mice after genetic rescue of perinatal death. J Neurosci 27:7183–7195CrossRefPubMed Ksiazek I, Burkhardt C, Lin S et al (2007) Synapse loss in cortex of agrin-deficient mice after genetic rescue of perinatal death. J Neurosci 27:7183–7195CrossRefPubMed
23.
Zurück zum Zitat Cohen NA, Kaufmann WE, Worley PF, Rupp F (1997) Expression of agrin in the developing and adult rat brain. Neuroscience 76:581–596CrossRefPubMed Cohen NA, Kaufmann WE, Worley PF, Rupp F (1997) Expression of agrin in the developing and adult rat brain. Neuroscience 76:581–596CrossRefPubMed
24.
Zurück zum Zitat Ma E, Morgan R, Godfrey EW (1995) Agrin mRNA variants are differentially regulated in developing chick embryo spinal cord and sensory ganglia. J Neurobiol 26:585–597CrossRefPubMed Ma E, Morgan R, Godfrey EW (1995) Agrin mRNA variants are differentially regulated in developing chick embryo spinal cord and sensory ganglia. J Neurobiol 26:585–597CrossRefPubMed
25.
Zurück zum Zitat McAvoy M, Smith MA, Fujii JT (1996) Agrin mRNA expression in the developing chick Edinger-Westphal nucleus. Vis Neurosci 13:293–301CrossRefPubMed McAvoy M, Smith MA, Fujii JT (1996) Agrin mRNA expression in the developing chick Edinger-Westphal nucleus. Vis Neurosci 13:293–301CrossRefPubMed
26.
Zurück zum Zitat Gingras J, Rassadi S, Cooper E, Ferns M (2007) Synaptic transmission is impaired at neuronal autonomic synapses in agrin-null mice. Dev Neurobiol 67:521–534CrossRefPubMed Gingras J, Rassadi S, Cooper E, Ferns M (2007) Synaptic transmission is impaired at neuronal autonomic synapses in agrin-null mice. Dev Neurobiol 67:521–534CrossRefPubMed
28.
Zurück zum Zitat Weatherbee SD, Anderson KV, Niswander LA (2006) LDL-receptor-related protein 4 is crucial for formation of the neuromuscular junction. Development 133:4993–5000CrossRefPubMed Weatherbee SD, Anderson KV, Niswander LA (2006) LDL-receptor-related protein 4 is crucial for formation of the neuromuscular junction. Development 133:4993–5000CrossRefPubMed
31.
Zurück zum Zitat Singer W, Sandroni P, Opfer-Gehrking TL et al (2006) Pyridostigmine treatment trial in neurogenic orthostatic hypotension. Arch Neurol 63:513–518CrossRefPubMed Singer W, Sandroni P, Opfer-Gehrking TL et al (2006) Pyridostigmine treatment trial in neurogenic orthostatic hypotension. Arch Neurol 63:513–518CrossRefPubMed
Metadaten
Titel
The presence of dysautonomia in different subgroups of myasthenia gravis patients
verfasst von
Ana Nikolić
Stojan Perić
Tanja Nišić
Srdjan Popović
Miroljub Ilić
Vidosava Rakočević Stojanović
Dragana Lavrnić
Publikationsdatum
01.11.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Neurology / Ausgabe 11/2014
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-014-7465-x

Weitere Artikel der Ausgabe 11/2014

Journal of Neurology 11/2014 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.